Newsletter | January 28, 2025

01.28.25 -- Defining When To Implement Technologies To Support Commercial Growth

SPONSOR

A Full-Service Solution Partner Disrupting the Outsourcing Paradigm

inSeption Group offers a full-service solution designed to disrupt the current outsourcing paradigm, resurrecting a common-sense approach to rebuild business trust and confidence in a client’s selected vendor. Primarily focused on oncology, hematology, neurodegenerative disorders, and rare/orphan disease indications, with a specialization in cell and gene therapy, inSeption has been a solution for its’ clients who have experienced the progressive degradation of today’s outsourcing options. Contact them.

FEATURED EDITORIAL

Defining When To Implement Technologies To Support Commercial Growth

Technology decisions must be understood in the context of your business strategy and projected milestones. With a framework in place, you can define what tech solution you need and when you need it.

INDUSTRY INSIGHTS

Time, Logistics, And Manufacturing In Autologous Cell Therapy Clinical Trials

Learn how the establishment of effective guidelines and standardization relevant to cell therapy development can help to minimize delays and lead to more positive outcomes.

Cold Chain Services For Clinical Trial Success

As innovative, complex therapeutics advance toward clinical trials, properly handling, storing, and packaging temperature-sensitive critical materials is essential to maintain product integrity.

Adapting Drug Supply Strategies To Modern Study Models

Advancements like remote-access drug refrigerators and smart packaging highlight the need for patient-centric trial models that integrate virtual and site-based activities to meet diverse patient needs.

SOLUTIONS

Supply Chain Management

Adding eCOA To RTSM: Simplifying Workflow For Sites

Perceptive eClinical: Clinical Trial Solutions